Benefits and Risks of Drug Combination Therapy for Chronic Metabolic Diseases

  • 18k

    Total downloads

  • 51k

    Total views and downloads

About this Research Topic

Submission closed

Background

Chronic metabolic diseases with increasing prevalence and morbidity have posed serious challenges to the global healthcare system and medical economy. Despite the emergence of innovative therapies with promising therapeutic effects, there are still a number of clinical issues that need to be addressed, including but not limited to how to deal with poor even no effectiveness of first-line drugs, how conventional drugs could be repositioned for new diseases, and whether the multi-drug combination therapy could be cost-effective and beneficial to improve patients’ quality of life. Therefore, in order to improve the therapeutic effect of drugs for chronic metabolic diseases, it is pertinent to carry out comprehensive evaluation and research on drug indications for the nonresponsive patient group, benefits and risks of drug combination scheme, and also pharmacoeconomics for the treatment of chronic metabolic diseases.

The theme of this study will focus on the "clinical -- basic -- clinical" research pathway, which involves three key topics specifically: (1) Drug indications for chronic metabolic diseases; (2) Magnitude of clinical benefits of multi-drug combination and the underlying mechanism of such benefits; (3) Pharmacoeconomic evaluation of multidrug combination in chronic metabolic diseases. It aims to better understand the drug selection, interaction mechanisms of existing drugs, and clinical benefits and risks of available treatment options targeting metabolic diseases. The types of articles include but are not limited to experimental research related to the mechanisms of potential treatments (drugs, foods, Chinese prescriptions, etc.), as well as post-hoc analyses of clinical trials, and real-world studies.

This Research Topic aims to seek solutions to meet the clinical needs of drug therapy for chronic metabolic diseases. Specifically, we will focus on exploring the potential of new use of conventional drugs, investigating the treatment outcomes of alternative strategies for certain patient groups that have poor even no effectiveness of first-line drugs, analyzing the clinical benefits and risks of multi-drug combination, assessing the cost-effectiveness and other unsolved problems in clinical practice. It will cover intersecting fields, including the employment of evidence-based approaches to evaluate the treatments’ effectiveness and safety, pharmacoeconomic analysis to estimate the cost-effectiveness of drugs, new technologies of omics, big data analysis and artificial intelligence to identify the targetable biomarkers.

Potential topics include but are not limited to:
• Conventional drugs in new use: exploring the new treatment potential of traditional medicines (traditional Chinese medicine, Chinese prescription preparation, Indian medicine, etc) via drug combinations or drug repositioning; Specifically, only traditional medicines where active ingredients have been identified would be considered relevant.
• Discovery of new drugs: research and development of new drugs for metabolic diseases to improve effectiveness and alleviate adverse effects;
• Research on mechanism of drugs: investigation of the mechanism of clinical drugs, such as the influence on cell transporter, metabolic enzymes, and important biological events;
• Application of new technology: using new technology, new methods (e.g., research of omics, space metabolism, artificial intelligence analysis, single cell sequencing, etc.) to study the mechanism of drug interactions;
• Drug selection strategy: exploring the optimal drug use strategies; investigating the effectiveness and safety of innovative drugs through randomized controlled trials, observational studies and real-world studies;
• Pharmacoeconomic evaluation to assess the cost-effectiveness of existing treatments and provide implications for manufacturers and healthcare payers to support the policy-making and implementation;
• Evidence-based evaluation of drugs and health economics research: evaluating the effectiveness and safety of the combination of existing drugs through meta-analysis; developing clinical guidelines or health technology reports to synthesize the clinical evidence and generate recommendations for clinical practice.

Keywords: chronic metabolic diseases, drug-drug interaction, indication of medication use, action mechanism, clinical evidence

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 51kTopic views
  • 32kArticle views
  • 18kArticle downloads
View impact